New England Compounding Center

Form 483 issued February 10, 2003 · Framingham, Massachusetts

Inspection
Feb 10, 2003
Observations
3
Pages
2
FEI number
3003623877

In short: On February 10, 2003, FDA issued a Form 483 with 3 observations to New England Compounding Center in Framingham, Massachusetts (FEI 3003623877) after an inspection that ran Feb 10, 2003. The investigators were David J. Pels and Karen M. Risi. Most observations concern quality system and production; the most-cited regulation is 21 CFR 211.198 (complaint files).

At a glance

2 of 3 observations on this 483 concern quality system.

Quality system2
Production1

Most cited: 21 CFR 211.198 (2×) · 211.113 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    For the preparation of sterile drug products distributed by your firm (such as those intended for…

  2. 02

    There are no written procedures pertaining to the handling of complaints, nor does your firm…

  3. 03

    There was no documentation available for the handling and disposition ofreports ofpatient problems, complaints, adverse dmg…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at New England Compounding Center?

FDA listed 3 observations on this Form 483, mostly about quality system and production. The most-cited regulation is 21 CFR 211.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected New England Compounding Center?

David J. Pels and Karen M. Risi are named on this Form 483, for the inspection of Feb 10, 2003. Each investigator has a profile showing what they cite most.

When was New England Compounding Center inspected by FDA?

The inspection ran Feb 10, 2003, and the Form 483 is dated February 10, 2003.

How do I get the full Form 483 for New England Compounding Center?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free